Genetic cause of hyperglycaemia and response to treatment in diabetes
- 1 October 2003
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 362 (9392), 1275-1281
- https://doi.org/10.1016/s0140-6736(03)14571-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Dominant-negative Suppression of HNF-1α Results in Mitochondrial Dysfunction, INS-1 Cell Apoptosis, and Increased Sensitivity to Ceramide-, but Not to High Glucose-induced Cell DeathJournal of Biological Chemistry, 2002
- Different genes, different diabetes: lessons from maturity-onset diabetes of the youngAnnals of Medicine, 2002
- Fructosamine, Hemoglobin A1c, and Measures of Diabetic ControlDiabetes Technology & Therapeutics, 1999
- Defective Pancreatic β-Cell Glycolytic Signaling in Hepatocyte Nuclear Factor-1α-deficient MicePublished by Elsevier BV ,1998
- Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.JCI Insight, 1998
- Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.JCI Insight, 1997
- United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three yearsBMJ, 1995
- Maturity‐Onset Diabetes of the YoungActa Paediatrica, 1989
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985
- Pharmacogenetics of tolbutamide metabolism in humansDiabetes, 1979